MGRM: Monogram Technologies Inc. Stock

by  •  • Comments Off on MGRM: Monogram Technologies Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 104.81
Enterprise Value ($M) 89.16
Book Value ($M) 16.02
Book Value / Share 0.45
Price / Book 6.54
NCAV ($M) 14.53
NCAV / Share 0.41
Price / NCAV 7.21

Profitability (mra)
Return on Invested Capital (ROIC) -0.90
Return on Assets (ROA) -1.18
Return on Equity (ROE) -1.45

Liquidity (mrq)
Quick Ratio 10.51
Current Ratio 10.70

Balance Sheet (mrq) ($M)
Current Assets 16.28
Assets 17.76
Liabilities 1.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -15.30
Net Income -14.81
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -13.97
Cash from Investing -0.08
Cash from Financing 16.12

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2024 ☐ Transition Report pursuant to Secti
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 7,817 57,414 13.62
2025-04-28 6,811 39,691 17.16
2025-04-25 18,121 59,148 30.64
2025-04-24 4,789 35,968 13.31

(click for more detail)

Similar Companies
MBOT – Microbot Medical Inc. MDAI – Spectral AI, Inc.
MDXG – MiMedx Group, Inc. MODD – Modular Medical, Inc.
MOVE – Movano Inc.


Financial data and stock pages provided by
Fintel.io